Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Pfizer signs $6bn licensing deal with China's 3SBio for cancer drug
03:07am, Tuesday, 20'th May 2025
Pfizer Inc (NYSE:PFE, ETR:PFE) has agreed a licensing deal worth up to $6 billion with Chinese biopharmaceutical group 3SBio to develop and commercialise an experimental cancer treatment. The drug, S
Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug
08:36pm, Monday, 19'th May 2025
Pfizer has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc for the development, manufacturing and commercialization of a drug undergoing tr
Pfizer Enters into Exclusive Licensing Agreement with 3SBio
08:00pm, Monday, 19'th May 2025
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutic
Buy These 2 Beaten Down Stocks Now Before They Rally
01:00pm, Monday, 19'th May 2025
I'm recommending two beaten-down REITs, American Assets Trust and Alexandria Real Estate, as long-term dividend plays with strong fundamentals and well-covered yields. Both stocks face near-term headw
PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now?
09:30am, Monday, 19'th May 2025
Both PFE and MRK have strong product and pipeline portfolios in oncology.
Astellas Presents New Data that Explores Potential of its Cancer Therapies at 2025 ASCO Annual Meeting
08:00am, Monday, 19'th May 2025
16 abstracts, including two oral presentations, feature new clinical data from Astellas' oncology portfolio TOKYO , May 19, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Nao
High-Yield Dividend Portfolios Outperform: These Are Our 5 Favorite Stock Picks
07:47am, Monday, 19'th May 2025
Investors love dividend stocks, especially the high-yield variety, because they offer a significant income stream and have massive total return potential.
Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
12:05pm, Sunday, 18'th May 2025
Dividend stocks can be a smart way to generate steady income, especially in uncertain markets. However, not all dividend payers are created equal.
Pfizer's Turnaround Story Is Stronger Than You Think
02:32pm, Friday, 16'th May 2025
On April 29, 2025, Pfizer beat consensus EPS estimates for the twelfth consecutive quarter by a wide margin, creating a divergence with its stock price, which continues to move sideways. I was pleasan
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:05am, Friday, 16'th May 2025
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 Game-Changing Additions To Your Retirement Income Portfolio
09:15am, Friday, 16'th May 2025
Retirement income investing should prioritize risk management, income stability, and capital preservation over aggressive growth strategies. To achieve that, investors tend to allocate high-quality va
Here's How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income
04:49am, Friday, 16'th May 2025
Looking for income? You might want to check out Pfizer (PFE 2.57%).
US House panel seeks information from Pfizer over alleged COVID vaccine delay
05:18pm, Thursday, 15'th May 2025
U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research executives intentionally delayed clinical trial results of its COVID-19 va
New allegations about timing of Pfizer Covid vaccine passed to House panel
11:20am, Thursday, 15'th May 2025
A former Pfizer scientist said the timing of the 2020 vaccine results “wasn't a coincidence,” according to allegations provided by a rival drugmaker.
5 Low Price-to-Book Value Stocks to Buy in May
09:41am, Thursday, 15'th May 2025
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and SAN are some such stocks.
